These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 21603980)
1. Detection of Brk expression in non-small cell lung cancer: clinicopathological relevance. Fan C; Zhao Y; Liu D; Zhang X; Wang E Tumour Biol; 2011 Oct; 32(5):873-80. PubMed ID: 21603980 [TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer. Dai SD; Wang Y; Miao Y; Zhao Y; Zhang Y; Jiang GY; Zhang PX; Yang ZQ; Wang EH BMC Cancer; 2009 Jun; 9():178. PubMed ID: 19508730 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of lymphatic vessel density marked by D2-40 and E-cadherin expression in non-small-cell lung cancer. Jin S; Zhu W; Shi Q; Zhang Z; Guo R Med Oncol; 2012 Dec; 29(5):3157-61. PubMed ID: 22528515 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of cathepsin D expression in non-small cell lung cancer is conditional on apoptosis-associated protein phenotype: an immunohistochemistry study. Fan C; Lin X; Wang E Tumour Biol; 2012 Aug; 33(4):1045-52. PubMed ID: 22302483 [TBL] [Abstract][Full Text] [Related]
5. PBK/TOPK expression in non-small-cell lung cancer: its correlation and prognostic significance with Ki67 and p53 expression. Lei B; Liu S; Qi W; Zhao Y; Li Y; Lin N; Xu X; Zhi C; Mei J; Yan Z; Wan L; Shen H Histopathology; 2013 Nov; 63(5):696-703. PubMed ID: 24025073 [TBL] [Abstract][Full Text] [Related]
6. Overexpression and cytoplasmic accumulation of Hepl is associated with clinicopathological parameters and poor prognosis in non-small cell lung cancer. Miao Y; Wang L; Liu Y; Li AL; Liu SL; Cao HY; Zhang XP; Jiang GY; Liu D; Wang EH Tumour Biol; 2013 Feb; 34(1):107-14. PubMed ID: 23001926 [TBL] [Abstract][Full Text] [Related]
7. delta-Catenin promotes malignant phenotype of non-small cell lung cancer by non-competitive binding to E-cadherin with p120ctn in cytoplasm. Zhang JY; Wang Y; Zhang D; Yang ZQ; Dong XJ; Jiang GY; Zhang PX; Dai SD; Dong QZ; Han Y; Zhang S; Cui QZ; Wang EH J Pathol; 2010 Sep; 222(1):76-88. PubMed ID: 20593408 [TBL] [Abstract][Full Text] [Related]
8. ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours. Vicent S; López-Picazo JM; Toledo G; Lozano MD; Torre W; Garcia-Corchón C; Quero C; Soria JC; Martín-Algarra S; Manzano RG; Montuenga LM Br J Cancer; 2004 Mar; 90(5):1047-52. PubMed ID: 14997206 [TBL] [Abstract][Full Text] [Related]
9. IL-17F expression correlates with clinicopathologic factors and biological markers in non-small cell lung cancer. Li C; Ma X; Tan C; Fang H; Sun Y; Gai X Pathol Res Pract; 2019 Oct; 215(10):152562. PubMed ID: 31387805 [TBL] [Abstract][Full Text] [Related]
10. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer]. Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763 [TBL] [Abstract][Full Text] [Related]
11. [Expression of survivin and its clinical significance in non-small cell lung cancer]. Ren YJ; Zhang QY Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):504-7. PubMed ID: 16224523 [TBL] [Abstract][Full Text] [Related]
12. Expression of a phosphorylated form of ATF4 in lung and non-small cell lung cancer tissues. Fan CF; Miao Y; Lin XY; Zhang D; Wang EH Tumour Biol; 2014 Jan; 35(1):765-71. PubMed ID: 23975372 [TBL] [Abstract][Full Text] [Related]
13. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells. Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207 [TBL] [Abstract][Full Text] [Related]
14. Expression of E-cadherin in lung carcinoma, other than those with small cells (NSCLC). Grigoraş ML; Arghirescu TS; Folescu R; Talpoş IC; Gîndac CM; Zamfir CL; Cornianu M; Anghel MD; Levai CM Rom J Morphol Embryol; 2017; 58(4):1317-1325. PubMed ID: 29556623 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of NEDD9 is associated with altered expression of E-Cadherin, β-Catenin and N-Cadherin and predictive of poor prognosis in non-small cell lung cancer. Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Yang LH; Liu Y; Wang EH Pathol Oncol Res; 2013 Apr; 19(2):281-6. PubMed ID: 23086683 [TBL] [Abstract][Full Text] [Related]
16. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer. Tsubochi H; Sato N; Hiyama M; Kaimori M; Endo S; Sohara Y; Imai T Ann Thorac Surg; 2006 Oct; 82(4):1198-204. PubMed ID: 16996907 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205 [TBL] [Abstract][Full Text] [Related]
18. The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer. Liu J; Lin Y; Yang H; Deng Q; Chen G; He J Tumour Biol; 2011 Dec; 32(6):1113-21. PubMed ID: 21779982 [TBL] [Abstract][Full Text] [Related]
19. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer. Goncharuk VN; del-Rosario A; Kren L; Anwar S; Sheehan CE; Carlson JA; Ross JS Ann Diagn Pathol; 2004 Feb; 8(1):6-16. PubMed ID: 15129904 [TBL] [Abstract][Full Text] [Related]
20. p0071 interacts with E-cadherin in the cytoplasm so as to promote the invasion and metastasis of non-small cell lung cancer. Zhao H; Zhang D; Yang L; Wang E Mol Carcinog; 2018 Jan; 57(1):89-96. PubMed ID: 28898462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]